Exelixis
EXEL
#2109
Rank
C$10.22 B
Marketcap
$35.84
Share price
-1.53%
Change (1 day)
23.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: C$10.22 Billion

As of September 2024 Exelixis has a market cap of C$10.22 Billion. This makes Exelixis the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024C$10.22 B3.31%
2023C$9.89 B40.94%
2022C$7.02 B-4.09%
2021C$7.31 B-7.81%
2020C$7.94 B14.41%
2019C$6.94 B-13.75%
2018C$8.04 B-28.84%
2017C$11.30 B94.65%
2016C$5.80 B225.36%
2015C$1.78 B445.71%
2014C$0.32 B-72.81%
2013C$1.20 B43.83%
2012C$0.83 B28.14%
2011C$0.65 B-27.3%
2010C$0.89 B7.19%
2009C$0.83 B29.36%
2008C$0.64 B-26.91%
2007C$0.88 B-11.89%
2006C$1.00 B9.96%
2005C$0.91 B17.66%
2004C$0.77 B17.99%
2003C$0.65 B-12.19%
2002C$0.75 B-49.53%
2001C$1.48 B45.19%
2000C$1.02 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Exelixis was reported to be:

C$10.22 Billion
by Yahoo Finance info icon info icon
C$10.22 Billion
by CompaniesMarketCap info icon info icon
C$10.22 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
C$114.54 B 1,020.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$195.95 B 1,816.99%๐Ÿ‡ซ๐Ÿ‡ท France
C$402.85 B 3,840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$135.87 B 1,229.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$245.89 B 2,305.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$536.00 B 5,143.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$226.12 B 2,112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$47.92 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.70 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA